# ClinicalTrials.gov record NCT02981069

> PeptideScanner retained ClinicalTrials.gov record NCT02981069 at 2026-07-30T19:10:42.759Z. Its registry update date was 2023-07-20, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct02981069-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-07-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02981069-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02981069-exenatide-v1.json
- Content SHA-256: `8513599d0e86ce586d1bfa868df7a6b6cc5c567b3d632c62303198512829dc7f`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02981069 ([`ctg-observation-nct02981069-2023-07-20-b3befdbf6979`](#source-ctg-observation-nct02981069-2023-07-20-b3befdbf6979))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02981069 at 2026-07-30T19:10:42.759Z. Its registry update date was 2023-07-20, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02981069-2023-07-20-b3befdbf6979`](#source-ctg-observation-nct02981069-2023-07-20-b3befdbf6979))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02981069 at 2026-07-30T19:10:42.759Z. Its registry update date was 2023-07-20, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02981069-2023-07-20-b3befdbf6979`](#source-ctg-observation-nct02981069-2023-07-20-b3befdbf6979))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02981069-2023-07-20-b3befdbf6979`](#source-ctg-observation-nct02981069-2023-07-20-b3befdbf6979))

## Sources

<a id="source-ctg-observation-nct02981069-2023-07-20-b3befdbf6979"></a>
- **ClinicalTrials.gov record NCT02981069 · retained source version 2023-07-20:b3befdbf6979c4b5878eb1f2026e9657923457a72f843d18552c88f4c9557cde** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02981069) (`ctg-observation-nct02981069-2023-07-20-b3befdbf6979`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02981069." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02981069-exenatide-v1.json SHA-256: 8513599d0e86ce586d1bfa868df7a6b6cc5c567b3d632c62303198512829dc7f.